Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-03-10 @ 12:00 PM
Study NCT ID:
NCT01190267
Status:
COMPLETED
Last Update Posted:
2024-05-22
First Post:
2010-08-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
Sponsor:
Organon and Co
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P05897
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None